CD47 and neoplasm: The mechanism by which elevated CD47 expression leads to improved survival in these cancers is unknown, but it is not consistent with the ‘don’t eat me’ hypothesis, which predicts poorer survival due to decreased innate immune clearance of tumor cells bearing high CD47.